93 related articles for article (PubMed ID: 61908)
1. [The acid-base equilibrium during mouse lymphoblastic leukemia].
Schneiberg K; Rytwiński K; Bartnikowa W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):166-76. PubMed ID: 61908
[TBL] [Abstract][Full Text] [Related]
2. Treatment of spontaneous leukemia in AKR mice with chemotherapy, immunotherapy, or interferon.
Bekesi JG; Roboz JP; Zimmerman E; Holland JF
Cancer Res; 1976 Feb; 36(2 pt 2):631-9. PubMed ID: 1082796
[TBL] [Abstract][Full Text] [Related]
3. Adoptive immunotherapy and combined chemo-immunotherapy in transplantable leukaemia of AKR mice (TAL); occurrence of natural killers.
Schneiberg K; Rytwiński K; Tabeńska J
Haematologia (Budap); 1981; 14(2):137-46. PubMed ID: 7274781
[TBL] [Abstract][Full Text] [Related]
4. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
Duś D; Harlozińska A; Skriabin A; Richter R
Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
[TBL] [Abstract][Full Text] [Related]
5. Thymus-dependent cytokinetics in transplantable leukemia of AKR mice.
Schneiberg K; Rytwinski K; Bartnikowa W
Jpn J Exp Med; 1978 Apr; 48(2):97-103. PubMed ID: 713125
[TBL] [Abstract][Full Text] [Related]
6. [The effect of exogenous alkalization on cytokinetics and on the survival rate of mice with lymphoblastic leukemia].
Schneiberg K; Rytwiński K; Bartnikowa W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(6):852-9. PubMed ID: 64426
[TBL] [Abstract][Full Text] [Related]
7. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
Wustrow TP; Good RA
Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
[TBL] [Abstract][Full Text] [Related]
8. Permanent metabolic alkalosis in mice following splenectomy or thymectomy.
Schneiberg K; Rytwiński K; Kośmider S; Bartnikowa W
Jpn J Exp Med; 1974 Jun; 44(3):262-6. PubMed ID: 4436976
[No Abstract] [Full Text] [Related]
9. Prostaglandins in cells of the lymphoid system in AKR leukemia.
Karmali RA; Wustrow T; Thaler HT; Good RA
Cancer Res; 1984 Feb; 44(2):467-71. PubMed ID: 6692354
[TBL] [Abstract][Full Text] [Related]
10. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
Green WR
J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
[TBL] [Abstract][Full Text] [Related]
11. The action of interferon in transplantable lymphatic leukemia of Gross.
Stelmachowska A; Blach-Olszewska Z; Skurska Z
Arch Immunol Ther Exp (Warsz); 1970; 18(1):16-22. PubMed ID: 5438562
[No Abstract] [Full Text] [Related]
12. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
Green WR
J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
[TBL] [Abstract][Full Text] [Related]
13. AKR mouse leukemia cells in tissue culture. I. Establishment of leukemic cell line AKR 87 and its morphologic and biologic characteristics.
Duś D
Arch Immunol Ther Exp (Warsz); 1976; 24(5):713-25. PubMed ID: 187140
[TBL] [Abstract][Full Text] [Related]
14. [1H-NMR spectroscopy of the cell membranes of thymus lymphocytes in AKR mice].
Iushmanov VE; Erokhin VN; Dronova LM; Belich EI; Kurushin EA
Biofizika; 1986; 31(5):829-32. PubMed ID: 3778958
[TBL] [Abstract][Full Text] [Related]
15. [Non-phosphorylative transglycosylation in the serum and liver of mice with transplantable leukemia P388 and L1210].
Sobiech KA; Madej JA; Kotoński B
Pol Arch Weter; 1986; 26(3-4):49-58. PubMed ID: 3438186
[TBL] [Abstract][Full Text] [Related]
16. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
[TBL] [Abstract][Full Text] [Related]
17. A discrepancy in XC and oncogenicity assays for murine leukemia virus in AKR mice.
Hays EF; Vredevoe DL
Cancer Res; 1977 Mar; 37(3):726-30. PubMed ID: 189912
[TBL] [Abstract][Full Text] [Related]
18. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
Schwartz HS; Grindey GB
Cancer Res; 1973 Aug; 33(8):1837-44. PubMed ID: 4720795
[No Abstract] [Full Text] [Related]
19. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.
Veselý J; Cihák A
Cancer Res; 1977 Oct; 37(10):3684-9. PubMed ID: 71199
[TBL] [Abstract][Full Text] [Related]
20. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
Green WR
J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
